ライフサイエンスコーパス: nonreducing

1 ses (PKSs), Hpm8 (highly reducing) and Hpm3 (nonreducing).

2 Incubation with n-acetylserine, a nonreducing analogue of NAC, did not lower Ang II bindin

3 species of approximately 120 kDa under both nonreducing and reducing conditions on SDS-polyacrylamid

4 ed to the carboxylates of the I rings at the nonreducing and reducing ends of the IAI trisaccharide s

5 - and tri-Manp motifs that functionalize the nonreducing arabinan termini of LAM (ManLAM) in Mycobact

6 presence of but a single Manp residue on the nonreducing arabinan termini of LAM and also a complete

7 n further be separated into two subclasses: "nonreducing" ARO/CYCs, which act on nonreduced poly-beta

8 for the cleavage of substrates containing a nonreducing beta(1,2)-linked GlcNAc.

9 For fetal material the nonreducing chain termini are shown to be sparsely cappe

10 saccharide profile, degree of sulfation, and nonreducing chain termini.

11 alpha-L-Rhap(1-->2)alpha-L-Rhap motif at its nonreducing chain terminus, stressing the importance of

12 In the nonreducing condition, a 125-kDa band, which seems to co

13 e and can be performed in either reducing or nonreducing conditions (e.g., to preserve disulfide bond

14 raphic purification strategy performed under nonreducing conditions (to maintain cysteine disulfide s

15 he apparent molecular mass was 136 kDa under nonreducing conditions and 34 kDa under reducing conditi

16 protein bands of approximately 66 kDa under nonreducing conditions and a single 25 kDa band under re

17 Velocity sedimentation under reducing- and nonreducing conditions and co-immunoprecipitation experi

18 we prepared isolated bovine complex I under nonreducing conditions and employed the techniques of ma

19 e disulfide bond modification occurred under nonreducing conditions and was not an artifact of sample

20 , and was detectable under both reducing and nonreducing conditions as a 28-kD protein in BALF from t

21 lysis of H120C/H213C protein separated under nonreducing conditions demonstrated that the ectopic bon

22 to determine a DeltaGu value for E2cd under nonreducing conditions due to problems with reversibilit

23 ential reactivity of 6-CP under reducing and nonreducing conditions highlights the ability of radical

24 leads to "explosive" fibrillation only under nonreducing conditions implying the key role of the disu

25 kDa under reducing conditions, whereas under nonreducing conditions it presented multimeric assembly

26 Western analysis of the receptors under nonreducing conditions reveals that they can form hetero

27 s was similar between genotypes, EMSAs under nonreducing conditions showed increased DNA binding in p

28 wed by Western blotting after SDS-PAGE under nonreducing conditions suggested that several SIRP prote

29 y Cys residues provided a protein that under nonreducing conditions was fully oxidized.

30 Under nonreducing conditions where the interchain disulfide bo

31 acid 330 produced a monomer-sized band under nonreducing conditions which was converted upon reductio

32 When denatured by SDS under nonreducing conditions, a fraction of the CD39L4 protein

33 ulfate-polyacrylamide gel electrophoresis in nonreducing conditions, and electron microscopy revealed

34 tion by endoproteinase Lys-C performed under nonreducing conditions, as well as tandem MS experiments

35 Under nonreducing conditions, beta4 has a molecular mass excee

36 Interestingly, under nonreducing conditions, compounds 9 and 10 are not subst

37 SDS-polyacrylamide gel electrophoresis under nonreducing conditions, it was found that an intermolecu

38 Under nonreducing conditions, most of the norrin in the extrac

39 Under nonreducing conditions, ovulin participates in a high-mo

40 ass of 90 kDa and 100 kDa under reducing and nonreducing conditions, respectively.

41 tially more stable than wild-type IPK1 under nonreducing conditions, revealing that increased stabili

42 ormed high molecular weight aggregates under nonreducing conditions, suggesting an increased propensi

43 Under nonreducing conditions, the amino terminus was released

44 Under nonreducing conditions, the Cm and DeltaGu of CenAP30 we

45 rP(Sc)-like form could be accomplished under nonreducing conditions, without the need to disrupt the

46 n and LC-MS/MS analysis were conducted under nonreducing conditions.

47 trated a high molecular weight complex under nonreducing conditions.

48 mutations that cross-link sigma1 monomers in nonreducing conditions.

49 humans, where it exists as a homodimer under nonreducing conditions.

50 domain 1 (CTLD1) domains of PLA2R only under nonreducing conditions.

51 ctrophoretic migration under reducing versus nonreducing conditions.

52 a ladder of disulfide-linked multimers under nonreducing conditions.

53 )/rGel migrated as an 84-kDa homodimer under nonreducing conditions.

54 mers when samples were electrophoresed under nonreducing conditions.

55 ateaus at 2.5-5 microg/mL under reducing and nonreducing conditions.

56 he VFT were identified on Western blot under nonreducing conditions.

57 ed a partial mobility shift to 160 kDa under nonreducing conditions.

58 ange protein is different under reducing and nonreducing conditions.

59 exists in a monomer-dimer equilibrium under nonreducing conditions.

60 subunits differed under reducing compared to nonreducing conditions.

61 ximately 105, and approximately 85 kDa under nonreducing conditions.

62 cation, and reactivity with serum only under nonreducing conditions.

63 ial extracts with anti-YajL antibodies under nonreducing conditions.

64 d in purified portal rings by SDS-PAGE under nonreducing conditions.

65 or spontaneous disulfide cross-linking under nonreducing conditions.

66 Trehalose is a nonreducing disaccharide of glucose that functions as a

67 Trehalose is a highly stable, nonreducing disaccharide of glucose.

68 f 3,3'-neotrehalosadiamine (NTD), an unusual nonreducing disaccharide reported to have antibiotic pro

69 on HIV replication of trehalose, a nontoxic, nonreducing disaccharide that induces autophagy through

70 dependent induced morphogenesis, whereby the nonreducing disaccharide trehalose acts as a negative re

71 acial binding sites that can accommodate the nonreducing disaccharides is key for their strong impact

72 We find that nonreducing disaccharides, sucrose and trehalose, strong

73 es (n = 2), and aggravation from reducing to nonreducing disk displacement (n = 1).

74 nant forms of micro 1 seen in gels after the nonreducing disruption of virions are ds-linked dimers.

75 ide evidence that NS domains residing at the nonreducing end (NRE) are, on average, longer than those

76 of the terminal trisaccharide, having at the nonreducing end a GlcNAc or GalNAc, and bound them to BS

77 ing N-acyl and O-acetyl modifications at the nonreducing end and a critical 6-O-sulfate at the reduci

78 igosaccharides containing a galactose at the nonreducing end and a propargyl group at the reducing en

79 ccharides of N-glycan with a GlcNAc at their nonreducing end and found that the extended sugar moiety

80 ontaining an unsaturated uronate unit at the nonreducing end and two contiguous AT-binding sequences

81 binding subsites (-I, -II, and -III) for the nonreducing end and two glucose binding subsites (+I and

82 The disaccharide at the nonreducing end binds specifically; the other rings are

83 evans and to differentiate reducing-end from nonreducing end cross ring cleavages in levans.

84 Also, nonreducing end de-N-acetyl residue-enriched vaccines el

85 >/=1/10,000), but only vaccines enriched for nonreducing end de-N-acetyl residues by treatment with e

86 erminal 4,5-unsaturated glucuronic acid, the nonreducing end disaccharide moiety does not interact wi

87 e closely associated with positioning of the nonreducing end during catalysis.

88 also confirming that growth occurred at the nonreducing end following initiation on phosphatidylglyc

89 ains has to proceed from the reducing to the nonreducing end for a better yield.

90 ed UDP-sugars, consistent with growth at the nonreducing end for this enzyme.

91 h the azido group at the C-6 position of the nonreducing end fucose could elicit a strong IgG immune

92 d alpha2-3- or alpha2-6-linked to a terminal nonreducing end galactose, poly-LacNAc extended core-3 O

93 plex with an oligosaccharide acceptor with a nonreducing end GlcNAc that has a beta1-6-glycosidic lin

94 We also show that the carboxyl group on nonreducing end glucuronic acid in dodecasaccharide moti

95 sthydrolysis state in which the newly formed nonreducing end has already left the substrate binding p

96 the reducing end of cellobiose, leaving the nonreducing end intact in these products.

97 and masked as a 1,6-anhydro sugar, while the nonreducing end is activated as a free alkyne and masked

98 s contain neither the galactose at the Le(a) nonreducing end nor the fucose at the Le(x) reducing end

99 ohydrate-binding module (CBM) that binds the nonreducing end of beta-1,3-glucan chains, and an unchar

100 hibit specificity for either the reducing or nonreducing end of cellulose.

101 ution reveals that the GlcNAc residue at the nonreducing end of chitobiose makes extensive hydrophobi

102 n (GH18(C)) and releases chitobiose from the nonreducing end of chitooligosaccharides, therefore func

103 ked alpha-D-galacturonosyl residues onto the nonreducing end of homogalacturonan chains.

104 samines present as monosaccharides or at the nonreducing end of odd-numbered oligosaccharide substrat

105 ronate or beta-D-manuronate residues, at the nonreducing end of oligo-alginates in an exolytic fashio

106 the unsaturated Delta4,5 uronic acid at the nonreducing end of oligosaccharides resulting from prior

107 Sialic acids (Sia) form the nonreducing end of the bulk of cell surface-expressed gl

108 y to HC2 and both are near the less sulfated nonreducing end of the CS.

109 he C-6 position of the GlcNAc residue at the nonreducing end of the disaccharide.

110 ucing an azido-containing sialic acid to the nonreducing end of the galactosides through a sialyltran

111 The nonreducing end of the glycan is terminated with the cap

112 lternate additions of Glc and GlcUA onto the nonreducing end of the growing polysaccharide chain.

113 l" antithrombin binding site and also at the nonreducing end of the molecule, which is reported in in

114 ing if a GalNAc-4S residue is reached on the nonreducing end of the oligosaccharide.

115 A2 binds up to five sugar residues from the nonreducing end of the oligosaccharide.

116 luronic acid blocks from the reducing to the nonreducing end of the polymer following the initial ran

117 e 3 polysaccharide was shown to occur at the nonreducing end of the polysaccharide chain.

118 4, where the (GlcNAc)2 group arises from the nonreducing end of the substrate and is formed as the be

119 The nonreducing end of the substrate-binding site of human s

120 The nonreducing end of the sugar is positioned near the prot

121 nit MalF binds three glucosyl units from the nonreducing end of the sugar.

122 The nonreducing end of the xylose moiety of xylobiose binds

123 meric enzyme that releases fructose from the nonreducing end of various oligosaccharides and essentia

124 ith its C-terminus free and the GPI with its nonreducing end phosphoethanolamine bearing a free amino

125 ars to cleave chitooligosaccharides from the nonreducing end primarily by disaccharide units.

126 Here we show that the nonreducing end product formed by an N. crassa PMO is a

127 and (GlcNAc)4 where dimers cleaved from the nonreducing end reflect the most common binding and hydr

128 accumulated heparan sulfate exhibits unique nonreducing end structures with terminal N-sulfoglucosam

129 n bonding between Asn(462) and xylose at the nonreducing end subsite +2 was important for the higher

130 at 355 nm, producing fragment ions from the nonreducing end that do not contain the appended fluorop

131 hed to the phosphoethanolamine moiety at the nonreducing end to form GPI-linked peptides.

132 While assembly from the nonreducing end to the reducing end was more convergent

133 The enzyme sulfates the substrate from the nonreducing end toward the reducing end consecutively, l

134 hin sulfate (ECS), was designed to mimic the nonreducing end trisaccharide unit DEF of the sequence s

135 domain A binding site of CV-N than with the nonreducing end unit.

136 alogues with modification at the reducing or nonreducing end were synthesized using chemoenzymatic me

137 hand, synthesis from the reducing end to the nonreducing end yielded the mannopentaose with the desir

138 ity of the enzyme by impeding nonproductive (nonreducing end) binding.

139 1 at the residues immediately located at the nonreducing end, allowing the formation of an N-Ac domai

140 stic of neuraminic acid, particularly at the nonreducing end, may be important for processing and pre

141 -O-, 5-O- and 3,5-di-O-linked alpha-Araf and nonreducing end-units of alpha-Araf, Arap, beta-Galp and

142 ched to the phosphoethanolamine group at the nonreducing end.

143 eavage occurred from the reducing end or the nonreducing end.

144 to a growing chain of polysialic acid at the nonreducing end.

145 acid (HA) by addition to the reducing or the nonreducing end.

146 tment with beta-glycosidases that act at the nonreducing end.

147 ainly to the second glucose residue from the nonreducing end.

148 ly degraded from the reducing end toward the nonreducing end.

149 ivity and degrades the chitin chain from the nonreducing end.

150 nzyme contain a C4 gemdiol/keto group at the nonreducing end.

151 ccharides with Delta-4,5-unsaturation at the nonreducing end.

152 only lack the galactose residue at the Le(a) nonreducing end.

153 y added to the fifth xylose residue from the nonreducing end.

154 of glycosyl hydrolases (GH5) and by Cel6A, a nonreducing-end cellobiohydrolase from family GH6 with t

155 oside hydrolase Family 6 (GH6) CBHs act from nonreducing ends by an inverting mechanism and are prese

156 results suggest that glycosidases acting on nonreducing ends digest large amounts of xyloglucan in w

157 type that could be explained by an excess of nonreducing ends leading to a reinforced xyloglucan netw

158 plex predicts transfer of GPI-CWP toward the nonreducing ends of acceptor glycans in the cell wall.

159 by W58L was confirmed from both reducing and nonreducing ends of CNP-labeled oligosaccharide substrat

160 and sites farther away from the reducing and nonreducing ends of oligosaccharide substrates.

161 Importantly, both reducing and nonreducing ends of the bound ligand are completely expo

162 and 2-O-sulfo-iduronic acid residues at the nonreducing ends of the glycans as co-receptors for Shh.

163 ity of the fragmentation originates from the nonreducing ends of the glycans.

164 e modes by recognizing the structures of the nonreducing ends of the substrates.

165 gosaccharides with the sulfate esters at the nonreducing ends preferentially bind to the lectin.

166 ed cellodextrins modified at the reducing or nonreducing ends upon incubation with cellulose and cell

167 erified to a variety of mycolic acids at the nonreducing ends.

168 ific sulfates and monosaccharides from their nonreducing ends.

169 M 32 family members that target the terminal nonreducing galactose residue of mucin glycans.

170 ngum, indicating that the recognition of the nonreducing galactosyl is essentially conserved, whereas

171 ylated and its glycan antennae bear terminal nonreducing galactosyl residues in alpha1-3 linkage.

172 However, by nonreducing gel electrophoresis, wild-type TraV and espe

173 immunoblotting profile of the IgA using a 6% nonreducing gel verified the dimeric nature of the autoa

174 Activity was lost after nonreducing gelatin SDS-PAGE but not native gelatin PAGE

175 T-pilus-associated VirB2 migrated in nonreducing gels as a monomer and a disulfide-cross-link

176 Their mobilities on nonreducing gels suggest that angiopoietin-2 exists pred

177 FAbs reacted with soluble E2 protein only in nonreducing gels, indicating that the relevant epitopes

178 reduced and form mixed-disulfide species on nonreducing gels.

179 cies, as observed by electrophoresis through nonreducing gels.

180 und having a galactosyl moiety at C-4 of the nonreducing GlcNAc moiety bound in the low micromolar ra

181 ine synthase (CysK), was also induced by the nonreducing growth conditions.

182 The nonreducing Hpm3 is able to accept an N-acetylcysteamine

183 trons to the heterodisulfide-H(2) via F(420)-nonreducing hydrogenase or formate via formate dehydroge

184 se, formylmethanofuran dehydrogenase, F(420)-nonreducing hydrogenase, and formate dehydrogenase.

185 curs by constructing a mutant lacking F(420)-nonreducing hydrogenase.

186 with product that is further elaborated by a nonreducing iPKS (nrPKS) to yield a 1,3-benzenediol moie

187 dc5, the highly reducing IPKS, and Rdc1, the nonreducing IPKS, are required for the biosynthesis of r

188 Because the PT domain is common among nonreducing IPKSs, these mechanistic features should pro

189 ucing iterative PKS, Hpm8, cooperates with a nonreducing iterative PKS, Hpm3, to construct the advanc

190 Nonreducing iterative polyketide synthases (NR-PKSs) are

191 SAT domains in starter unit selection among nonreducing iterative, fungal PKSs, and they provide a b

192 ynthetic versatility of TE domains in fungal nonreducing, iterative PKSs (NR-PKSs) has been shown to

193 The nonreducing ligand l-tetrahydro-2-furoic acid mimics the

194 ) generated by FAD reduction relative to the nonreducing ligands demonstrates that FAD reduction cont

195 h carbohydrates possessing multiple terminal nonreducing Man residues.

196 ined the localization of N-glyans containing nonreducing mannosyl groups, accentuating the GNA vesicu

197 l variability of aromatic products of fungal nonreducing, multidomain iterative polyketide synthases

198 a combination of CNBr and chymotrypsin under nonreducing, nonalkylating conditions in combination wit

199 e tight binding of the nascent chain via its nonreducing oligosaccharide terminal segment to the carb

200 hares a high degree of similarity to another nonreducing PKS ARO/CYC, TcmN ARO/CYC.

201 ution of Gibberella zeae PKS13, which is the nonreducing PKS associated with zearalenone biosynthesis

202 th a sequential and convergent manner with a nonreducing PKS to form the chaetomugilin and chaetoviri

203 cture analysis of a group of related fungal, nonreducing PKSs has revealed well defined N-terminal do

204 we have replaced, en masse, the promoters of nonreducing polyketide synthase (NR-PKS) genes, key gene

205 A nonreducing polyketide synthase (NR-PKS) PhnA was shown

206 form the tropolone nucleus: tropA encodes a nonreducing polyketide synthase which releases 3-methylo

207 Iterative, nonreducing polyketide synthases (NR-PKSs) are multidoma

208 Product template (PT) domains from fungal nonreducing polyketide synthases (NR-PKSs) are responsib

209 The fungal iterative nonreducing polyketide synthases (NRPKSs) synthesize aro

210 und production and release from six of these nonreducing polyketide synthases and have identified the

211 We have validated this system by expressing nonreducing polyketide synthases of Aspergillus terreus

212 ctroscopy demonstrated that D239T could bind nonreducing pyridine nucleotides with a phosphate or a h

213 These triplets are formed under nonreducing redox conditions, when the recombination tri

214 acts on a YajL affinity column, separated by nonreducing-reducing SDS-PAGE, and identified by mass sp

215 ntional two-dimensional electrophoresis: (i) nonreducing/reducing or (ii) isoelectric focusing/reduci

216 d to various oxidative insults by sequential nonreducing/reducing two-dimensional SDS-PAGE combined w

217 e full complement of hydroxyl groups on the "nonreducing" ring.

218 trimer in SDS gels and a Mr 42,000 dimer) on nonreducing SDS gels.

219 otein with Cys28 appears as a homodimer in a nonreducing SDS polyacrylamide gel.

220 he appearance of disulfide-bonded species on nonreducing SDS--PAGE and protection of 4-OHEN-mediated

221 acid resulted in two radioactive species on nonreducing SDS-PAGE gels, with molecular weights corres

222 ng proteolytic enzymes are first resolved in nonreducing SDS-PAGE on a gel without protein substrate.

223 Nonreducing SDS-PAGE revealed that EB-localized apparatu

224 s and Western blots of proteins subjected to nonreducing SDS-PAGE suggested that all four 1F5 scFv-Ig

225 Proteins were also analyzed by nonreducing SDS-PAGE to show the covalent structure unde

226 of Forster resonance energy transfer (FRET), nonreducing SDS-PAGE, and strategic mutation of the Ab h

227 sulins exhibit abnormally slow mobility upon nonreducing SDS-PAGE, despite normal mobility upon reduc

228 g occurs as a discrete "jump" in mobility by nonreducing SDS-PAGE, suggesting formation of at most a

229 mass heterogeneity following reducing versus nonreducing SDS-PAGE, we determined that the beta-subuni

230 onal higher molecular mass material, seen by nonreducing SDS-PAGE.

231 e in the migration position of cPKC-alpha in nonreducing SDS-PAGE.

232 In nonreducing SDS-polyacrylamide gel electrophoresis (PAGE

233 rated at about 47.5 kDa on both reducing and nonreducing SDS-polyacrylamide gel electrophoresis, indi

234 nd with resulting downward mobility shift on nonreducing SDS-polyacrylamide gel electrophoresis.

235 the apparent molecular mass determined with nonreducing SDS/PAGE from approximately 85 to approximat

236 on of the intact sugar to be assigned to the nonreducing side of a glycosidic linkage.

237 highly conserved residues exclusively on the nonreducing side of its catalytic center.

238 ondroitin sulfation at the 4-position on the nonreducing site of the linkage to be cleaved or 2-sulfa

239 inhibition, and analysis of band patterns on nonreducing sodium dodecyl sulfate--polyacrylamide gel e

240 hilized, and subjected to electrophoresis on nonreducing sodium dodecyl sulfate-5% polyacrylamide gel

241 ovel VirB7 and VirB9 complexes detectable by nonreducing sodium dodecyl sulfate-polyacrylamide gel el

242 lar disulfide linkages that were revealed by nonreducing sodium dodecyl sulfate-polyacrylamide gel el

243 oresis of protease-containing samples into a nonreducing sodium dodecyl sulfate-polyacrylamide gel el

244 s, along with an in-depth comparison, of the nonreducing (StfQ) and reducing (BexL) di-domain ARO/CYC

245 sugars without the interferences from their nonreducing structural isomers in mouse heart tissue, wi

246 at m/z 221 anions are comprised of an intact nonreducing sugar glycosidically linked to a 2-carbon ag

247 or specificity is controlled by the terminal nonreducing sugar in the acceptor subsite.

248 ing H-bond is formed between the 2-OH of the nonreducing sugar ring and Arg349.

249 Trehalose is a nonreducing sugar used as a reserve carbohydrate and str

250 These included the nonreducing sugar, sucrose, as well as maltose, lactose,

251 which incorporate sialic acid as a terminal nonreducing sugar.

252 into the lipooligosaccharides as a terminal nonreducing sugar.

253 These exclusive interactions between the nonreducing sugars and the membranes may rationalize why

254 , which preferentially binds to a cluster of nonreducing terminal alpha1,3-linked mannosyl residues,

255 rom additional favorable interactions of the nonreducing terminal galactose, as well as of the fucose

256 ulfotransferases can transfer sulfate to the nonreducing terminal GlcNAc of short carbohydrate substr

257 branched, primarily with double branches of nonreducing terminal l-arabinosyl units at the O-2 and O

258 to Ca(2+) in a primary binding site and the nonreducing terminal mannose residue occupying an adjace

259 Here, we evaluated the influence of the nonreducing terminal monosaccharide on the serum antibod

260 proteins are involved in the assembly of the nonreducing terminal motif of arabinogalactan and EmbC i

261 beta1,4-galactosylation is the presence of a nonreducing terminal N-acetylglucosamine; however, this

262 bits highest specificity and affinity toward nonreducing terminal Neu5Acalpha2, 6Galbeta1,4Glc/GlcNAc

263 osamine-4-sulfate (GalNAc-4S) residue at the nonreducing terminal of GAG structures.

264 d to glycoproteins that bear these sugars in nonreducing terminal positions.

265 inding patterns, confirmed the presence of a nonreducing terminal repeating LacNAc ((Galbeta1-->4GlcN

266 onal immunoglobulin A (IgA) specific for the nonreducing terminal residue of Ogawa O-polysaccharide (

267 The nonreducing terminal residue of the pentasaccharide side

268 The rhamnogalacturonan I has numerous single nonreducing terminal residues of the rare sugar l-galact

269 The previously undescribed nonreducing terminal sugar (i.e. 2-O-methyl-4-(3-hydroxy

270 dase digestion confirmed the identity of the nonreducing terminal sugar of the disaccharide and estab

271 beta-Glucuronidase was used to remove nonreducing-terminal glucuronic acid residues from oligo

272 syl residues of N-acetyllactosamine close to nonreducing terminals.

273 with the antigenic structure located in the nonreducing termini (i.e., Fucalpha1-2Galbeta1-3GalNAc-R

274 ves beta-D-glucuronic acid residues from the nonreducing termini of glycosaminoglycans.

275 or more Manalpha1-2Manalpha moieties on the nonreducing termini of oligomannose structures.

276 oval of individual saccharide units from the nonreducing termini of the multiantennary structures.

277 hain oligosaccharides are substituted at the nonreducing termini with single 4-O-methyl-glucuronosyl

278 galactose residues (7- and 11-mers) at their nonreducing termini.

279 are rich in N-glycans with Galalpha1-4Gal at nonreducing termini.

280 (i.e. Galbeta1,3GlcNAc-) groups at its three nonreducing termini.

281 especially those with galactose units at the nonreducing termini.

282 at the fragments were consistent with an LTA nonreducing terminus consisting of GalNAc(alpha1-->3)Gal

283 hydroxyl group of a galactose residue at the nonreducing terminus of an oligosaccharide.

284 a second glycan repeat-unit structure to the nonreducing terminus of O2a.

285 carbohydrate epitope that is present at the nonreducing terminus of sugar chains of glycoproteins an

286 (alpha-GalNAc) is most notably found at the nonreducing terminus of the blood type-determining A-ant

287 ongation is inhibited by truncation when the nonreducing terminus of the growing chain is capped with

288 tituted xylose residue one position from the nonreducing terminus of the oligoxyloside product.

289 rms of Nz28, sequentially truncated from the nonreducing terminus, possess only one PEtn moiety.

290 the chemical modification of the O antigen's nonreducing terminus, sensed by WzmWzt via a carbohydrat

291 es in the N-glycan core, once exposed in the nonreducing terminus, was able to serve as acceptors for

292 cosamine (1-] with an N-acetyl-D-glucosamine nonreducing terminus.

293 chain by the addition of sugar units to the nonreducing terminus.

294 e to hydrolyze alpha2-8-linked Neu5Gc at the nonreducing terminus.

295 nd some number of xylose residues toward the nonreducing terminus.

296 accharides; alpha- and beta-cyclodextrins; a nonreducing tetrasaccharide, stachyose; an N-acetylamide

297 Upon nonreducing Tris-Tricine-urea-SDS-PAGE, newly synthesize

298 ed by reciprocal co-immunoprecipitation, and nonreducing velocity sedimentation was used to identify

299 sites residing outside of EC2 as assayed by nonreducing Western blot analysis, sedimentation velocit

300 ed form of wild-type gB was identified under nonreducing Western blot conditions that likely represen